Table 3.

Association of clinicopathological features with cIAP-1 mRNA expression in breast cancer patients.

Variables		cIAP-1 mRNA expression
		Mean ± SD	p value
Overall expression		13.50 ± 8.07	—
Age
<45		13.31 ± 8.69	0.66
>45		13.59 ± 7.83
TNM stage
Stage I		9.54 ± 2.91	0.004
Stage II		11.80 ± 8.50
Stage III		15.19 ± 8.16
Stage IV		16.83 ± 5.17
Distant metastases
Yes		16.83 ± 5.17	0.008
No		12.92 ± 8.37
Lymph node involvement
Yes		13.70 ± 8.72	0.98
No		13.27 ± 733
Menopause
Yes		13.24 ± 7.24	0.94
No		13.93 ± 8.81
ER expression
Yes		14.83 ± 9.18	0.28
No		12.58 ± 7.14
PR expression
Yes		19.57 ± 8.39	<0.0001
No		10.09 ± 5.52
HER2 expression
Yes		17.16 ± 7.80	<0.0001
No		9.37 ± 6.22
Smoking
Yes		21.50 ± 7.58	<0.0001
No		10.39 ± 5.83
Alcoholism
Yes		23.14 ± 6.33	<0.0001
No		8.96 ± 3.54